Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 169
Filter
1.
Int J Mycobacteriol ; 13(1): 96-99, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-38771286

ABSTRACT

BACKGROUND: The most common organ affected due to tuberculosis (TB) is the lungs. Extrapulmonary TB is less common. Musculoskeletal organs are affected in around 8% of all tubercular patients, of which the spine is affected in almost half of the patients. The criteria for diagnosing spinal TB are quite difficult and we use an array of investigations for the same. METHODS: A retrospective study was carried out in the Neurosurgery and Microbiology Department at IMS and SUM Hospital between January 2021 and November 2023, and data were collected and tabulated in an Excel sheet. One hundred patients with spinal TB were evaluated, and their age, sex, samples sent, diagnostic investigation, duration of diagnosis from hospital admission, histopathology results, and surgical intervention (done or not) were recorded. RESULTS: The best investigation done to diagnose spinal TB was imaging and surgical/computed tomography (CT)-guided biopsy. The earliest result to diagnose spinal TB was histopathology. The yield of positivity in pus culture, smear microscopy, and true nucleic acid amplification test (NAAT) was found to be low even though sensitivity was on the higher side. CONCLUSION: Even though we have an array of investigations for diagnosing spinal TB, the best and the earliest diagnosing test was imaging plus CT-guided biopsy. The confirmation is made in the biopsy. Finding acid-fast bacteria (AFB) and NAAT tests are additional beneficial tests to supplement the diagnosis. Hence, we can conclude that sending for tests like AFB in pus, NAAT, and GeneXpert is a wastage of biological samples and delays in diagnosis.


Subject(s)
Mycobacterium tuberculosis , Tuberculosis, Spinal , Humans , Tuberculosis, Spinal/diagnosis , Tuberculosis, Spinal/microbiology , Retrospective Studies , Male , Female , Adult , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Mycobacterium tuberculosis/genetics , Young Adult , Aged , Tomography, X-Ray Computed , Adolescent , Biopsy , Nucleic Acid Amplification Techniques/methods , Sensitivity and Specificity
2.
Sci Rep ; 12(1): 149, 2022 01 07.
Article in English | MEDLINE | ID: mdl-34997091

ABSTRACT

In recent years, with the in-depth research on spinal tuberculosis, posterior surgery alone has been praised highly by more and more surgeons due to the better correction of kyphosis, better maintenance of spinal physiological curvature, smaller surgical trauma and fewer surgical complications. However, there is currently lack of relevant reports about the efficacy of posterior surgery alone in the treatment of tuberculosis in the T4-6 segments. This study aimed to evaluate the clinical study efficacy and feasibility of one-stage posterior-only surgical treatment for thoracic spinal tuberculosis in the T4-6 segments. 67 patients with tuberculosis in T4-6 segments who underwent one-stage posterior-only surgery were included in this study. The clinical efficacy was evaluated using statistical analysis based on the data about erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Oswestry Dability Index (ODI) score, Visual Analogue Scale (VAS) score and Cobb angle before surgery, after surgery and at the last follow-up. All patients completed fusion during the follow-up period of 6-9 months. ESR and CRP were returned to normal for all patients at 6 months follow-up. In the meanwhile, among the 27 patients combined with neurological impairment, neurological functions of 22 cases (81.48%) recovered completely at the last follow-up (P < 0.05). Cobb angle of the kyphosis was improved from preoperative 34.8 ± 10.9° to postoperative 9.6 ± 2.8°, maintaining at 11.3 ± 3.2° at the last follow-up, The ODI and VAS scores were improved by 77.10% and 81.70%, respectively. This 5-year follow-up study shows that better clinical efficacy can be achieved for tuberculosis in T4-6 segments using one-stage posterior-only approach by costotransverse debridement in combination with bone graft and internal fixation. The posterior surgical method cannot only effectively accomplish debridement, obtain satisfactory clinical results, but also well correct kyphotic deformity and maintain it.


Subject(s)
Bone Transplantation , Debridement , Kyphosis/surgery , Spinal Fusion , Thoracic Vertebrae/surgery , Tuberculosis, Spinal/surgery , Adult , Bone Transplantation/adverse effects , Debridement/adverse effects , Feasibility Studies , Female , Follow-Up Studies , Humans , Kyphosis/diagnostic imaging , Kyphosis/microbiology , Kyphosis/physiopathology , Male , Middle Aged , Postoperative Complications/etiology , Recovery of Function , Spinal Fusion/adverse effects , Therapeutic Irrigation , Thoracic Vertebrae/diagnostic imaging , Thoracic Vertebrae/microbiology , Thoracic Vertebrae/physiopathology , Time Factors , Treatment Outcome , Tuberculosis, Spinal/diagnostic imaging , Tuberculosis, Spinal/microbiology , Tuberculosis, Spinal/physiopathology
3.
BMJ Case Rep ; 15(12)2022 Dec 09.
Article in English | MEDLINE | ID: mdl-36593635

ABSTRACT

Intravesical BCG therapy is commonly used to treat superficial bladder cancer. Although various complications associated with this therapy have been reported, tuberculous spondylitis is uncommon. Here, we report a rare case of tuberculous spondylitis that occurred after intravesical BCG therapy for bladder cancer. A man in his 80s received BCG immunotherapy for bladder cancer and developed low back pain after treatment. Remarkably, he presented with neurological symptoms. Spondylitis was suspected on imaging. CT-guided biopsy was performed to confirm the diagnosis. Consequently, Mycobacterium bovis was identified as the causative pathogen by multiplex PCR. Multidrug therapy, administered for several months, was ineffective. Therefore, surgery was performed through an anterior approach. The symptoms, including low back pain, improved and postoperative C reactive protein tests were within the normal range. Tuberculous spondylitis following BCG therapy should be considered in cases with a history of bladder cancer treatment.


Subject(s)
BCG Vaccine , Low Back Pain , Mycobacterium bovis , Spondylitis , Tuberculosis, Spinal , Urinary Bladder Neoplasms , Humans , Male , Administration, Intravesical , BCG Vaccine/adverse effects , BCG Vaccine/therapeutic use , Drug Therapy, Combination , Leprostatic Agents/therapeutic use , Low Back Pain/diagnostic imaging , Low Back Pain/etiology , Spondylitis/diagnosis , Spondylitis/microbiology , Tuberculosis, Spinal/diagnosis , Tuberculosis, Spinal/microbiology , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/surgery , Urinary Bladder Neoplasms/complications , Aged, 80 and over
4.
Eur J Med Res ; 26(1): 125, 2021 Oct 28.
Article in English | MEDLINE | ID: mdl-34711265

ABSTRACT

BACKGROUND: Brucella spondylitis (BS) and tuberculous spondylitis (TS), caused initially by bacteremia, are the two leading types of granulomatous spinal infections. BS is easy to miss or may be misdiagnosed as TS. Our purpose aims to differentiate BS from TS in conventional MR imaging and MR T2 mapping. METHODS: We performed on 26 BS and 27 TS patients conventional MR imaging and MR T2 mapping. We analyzed the features in conventional MR imaging and measured T2 values of the lesion vertebrae (LV) and unaffected adjacent vertebrae (UAV) in BS and TS patients, respectively. RESULTS: There were no significant differences in sex, age, national between BS and TS. There was significantly lower severity of vertebral destruction, vertebral posterior convex deformity, dead bone, and abscess scope in BS when compared to TS (p < 0.001, p = 0.048, p < 0.001, p < 0.001, respectively). The vertebral hyperplasia was significantly higher in BS when compared to TS (p < 0.001). The T2 value of the LV with BS was markedly higher than that in the UAV with BS and that in the LV and UAV with TS (p < 0.001, p < 0.037, p < 0.001, respectively). The T2 value of the LV with TS was significantly higher than that of the UAV in TS and BS (p < 0.001, p < 0.001, respectively). There were no significant differences in the T2 value of the UAV between BS and TS (p = 0.568). CONCLUSIONS: The qualitative and quantitative evaluation may differentiate BS from TS. The conventional MR imaging helps to distinguish BS from TS by several distinctive features. MR T2 mapping has the additional potential to provide quantitative information between BS and TS.


Subject(s)
Brucella/isolation & purification , Brucellosis/diagnosis , Diagnostic Imaging/methods , Magnetic Resonance Imaging/methods , Spondylitis/diagnosis , Tuberculosis, Spinal/diagnosis , Adolescent , Adult , Aged , Brucellosis/microbiology , Diagnosis, Differential , Humans , Lumbar Vertebrae/microbiology , Male , Middle Aged , Prospective Studies , Spondylitis/microbiology , Thoracic Vertebrae/microbiology , Tuberculosis, Spinal/microbiology , Young Adult
5.
Tuberculosis (Edinb) ; 126: 102039, 2021 01.
Article in English | MEDLINE | ID: mdl-33316736

ABSTRACT

Tuberculosis infection activates the autoimmune system. However, the role of host-pathogen interactions involved in Mycobacterium tuberculosis infection is unclear. In this study, we analyzed 6 spinal tuberculosis tissues and 6 herniated disc tissues by using liquid chromatography-tandem mass spectrometry coupled with tandem mass spectrometry, and immunohistochemical staining was performed for validating the results. We identified 42 differential immune-related proteins and 3 hub genes that are primarily localised in the tertiary granule and involved in biological processes such as cellular response to the presence of cadmium ions, regulation of ion transmembrane transport, transmembrane transport, and inflammatory responses. Genes encoding cytochrome B-245 beta chain (CYBB), matrix metallopeptidase 9 (MMP9), and C-X-C motif chemokine ligand 10 (CXCL10) were identified as the hub genes that exhibited anti-tuberculosis activity and were responsible for macrophage resistance against M. tuberculosis. In conclusion, CYBB, MMP9, and CXCL10 resist M. tuberculosis infection through chemotaxis and macrophage activation. Our results indicate that CYBB, MMP9, and CXCL10 could be considered as molecular targets for spinal tuberculosis treatment, which may significantly improve patients' quality of life and prognosis.


Subject(s)
Cervical Vertebrae , Intervertebral Disc/microbiology , Macrophages/immunology , Mycobacterium tuberculosis/isolation & purification , Proteomics/methods , Thoracic Vertebrae , Tuberculosis, Spinal/microbiology , Chondrocytes/microbiology , Chondrocytes/pathology , Fibroblasts/microbiology , Fibroblasts/pathology , Humans , Immunity, Cellular , Macrophages/microbiology , Radioimmunoprecipitation Assay , Retrospective Studies , Tuberculosis, Spinal/immunology , Tuberculosis, Spinal/pathology
6.
Pak J Biol Sci ; 23(11): 1492-1495, 2020 Jan.
Article in English | MEDLINE | ID: mdl-33274880

ABSTRACT

Pott's disease is a form of spondylodiscitis caused by mycobacterium tuberculosis. It is a serious form of spinal infections that can lead to terrible disabilities in case of undiagnosed and treated early. To document a case of Pott's paraplegia cured after four years. This report details the case of a patient with an undiagnosed case of spinal tuberculosis in a 55-year-old man who had complained of lower back pain and tenderness over the course of several months. The case progressed to the point that he had difficulty standing and numbness, then weakness, of the lower limbs. This patient was only treated with analgesics and antibiotics. Herbal remedies, massage and amulets also played a major role in his treatment. The patient remained bed-bound and paraplegic for four years, after which, he was referred for a thoracolumbar Magnetic Resonance Imaging (MRI) and was diagnosed with tuberculous spondylodiscitis. The patient underwent decompression surgery and started anti-tuberculous drugs. He regained his ability to walk. His lifestyle has improved and he has been living independently for eight years. In conclusion, diagnosis and correct treatment can result in a patient who was previously handicapped becoming independent once again. Medical imaging using MRI can play an essential role in the diagnosis of spinal lesions, including those present in cases of Pott's disease.


Subject(s)
Antitubercular Agents/therapeutic use , Decompression, Surgical , Tuberculosis, Spinal/therapy , Combined Modality Therapy , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Recovery of Function , Time Factors , Treatment Outcome , Tuberculosis, Spinal/diagnostic imaging , Tuberculosis, Spinal/microbiology , Tuberculosis, Spinal/physiopathology
7.
BMJ Case Rep ; 13(5)2020 May 14.
Article in English | MEDLINE | ID: mdl-32414775

ABSTRACT

It is uncommon to get lumbosacral junction deformity due to tuberculosis. Lumbosacral junction alignment is of paramount importance in maintaining global sagittal balance. In this case report, we present a case of a 42-year-old woman with multidrug-resistant tuberculosis of lumbosacral spine with complete destruction of L3, L4 and L5 vertebra with partial destruction of L2 and S1 vertebra leading to significant shortening and lumbosacral kyphosis. The patient had severe axial low back pain, inability to sleep in supine position due to deformity and difficulty in walking due to loss of spinal alignment. The patient was treated with 6 weeks of antituberculous drugs followed by all posterior decompression with instrumentation from D10 to S2 with a reconstruction of anterior vertebral bodies with the help of an expandable cage. Antituberculous treatment was continued for 18 months. At present, the patient is asymptomatic with no neurological deficit and has completed 3.5 years of regular follow-up.


Subject(s)
Antitubercular Agents/therapeutic use , Kyphosis/microbiology , Kyphosis/therapy , Tuberculosis, Multidrug-Resistant/complications , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Spinal/microbiology , Tuberculosis, Spinal/therapy , Adult , Combined Modality Therapy , Diagnosis, Differential , Female , Humans , Kyphosis/diagnostic imaging , Lumbar Vertebrae , Spinal Fusion , Tuberculosis, Spinal/diagnostic imaging
8.
Biomed Res Int ; 2020: 9871390, 2020.
Article in English | MEDLINE | ID: mdl-32076625

ABSTRACT

Spinal tuberculosis (STB), which is the most frequent and serious form of skeletal TB, is seriously harmful to a patient's life. However, very little research has been conducted on clinical isolates of STB. The purpose of this study was to genotype clinical isolates of Mycobacterium tuberculosis (MTB) from patients with STB, investigate their drug resistance profiles, and determine whether the genotypes and drug resistance patterns share any relationships with the demographic and clinical features of the patients. Preliminary species identification of the MTB strains was performed using a TCH/PNB culture method and multilocus polymerase chain reactions. Of the specimens collected from 85 hospital in-patients with STB at Xiangya Hospital, China, the 56 culture-positive MTB strains we identified were genotyped by spoligotyping. The strains were tested for resistance to anti-tuberculosis drugs (ATDs), and the demographic and clinical features of the patients were analyzed in combination with the genotyping and drug resistance results. Of the 56, cases, 53 involved M. tuberculosis and 3 involved M. bovis. Spoligotyping revealed 27 Beijing-type cases and 29 nonBeijing cases. When patients with STB were relapsing or experiencing systemic toxicity signs/symptoms (STS), the Beijing MTB-type strains predominated (p < 0.05), but when the patients were receiving initial treatment or lacked STS, the nonBeijing type MTB strains dominated. The Beijing and nonBeijing types differed in their resistance patterns to 8 ATDs, and the resistance rate of the Beijing type was higher than that of the nonBeijing type (p < 0.05). The bacteriological features of STB, including genotype and drug resistance, shared close relationships with the clinical features of patients with STB. Our data provide a reference for the diagnosis and treatment of STB.


Subject(s)
Drug Resistance, Multiple, Bacterial/genetics , Genotype , Mycobacterium tuberculosis/genetics , Tuberculosis, Spinal/microbiology , Antitubercular Agents/pharmacology , Antitubercular Agents/therapeutic use , Beijing , China , Female , Humans , Male , Mycobacterium bovis/drug effects , Mycobacterium bovis/genetics , Mycobacterium tuberculosis/drug effects , Tuberculosis, Multidrug-Resistant/microbiology
9.
J Zoo Wildl Med ; 50(4): 1000-1004, 2020 Jan 09.
Article in English | MEDLINE | ID: mdl-31926536

ABSTRACT

Mycobacterium orygis, a newly identified member of the Mycobacterium tuberculosis complex, has been isolated predominantly from hoofstock in eastern Africa and the Arabian Peninsula, and sporadically in cattle (Bos taurus indicus), rhesus monkeys (Macaca mulatta), humans, and a greater one-horned rhinoceros (Rhinoceros unicornis) in South Asia. In rhinoceros, tuberculosis typically presents as a chronic progressive respiratory disease. The report describes the postmortem diagnosis of tuberculosis caused by Mycobacterium orygis in a greater one-horned rhinoceros with hind limb paresis due to neural granulomatosis. Serologic assays for detection of antibodies to M. tuberculosis complex proteins before culture results allowed for appropriate herd management protocols to be initiated. Mycobacterium genus-specific polymerase chain reaction assays with direct sequencing allowed timely confirmation of the serologic results. This is the first isolation of M. orygis in the western hemisphere, showing the need for mycobacterial testing of rhinoceros before international shipments and the urgency for validated antemortem M. tuberculosis complex screening assays in rhinoceros species.


Subject(s)
Mycobacterium/isolation & purification , Perissodactyla/microbiology , Tuberculosis, Spinal/veterinary , Animals , Animals, Zoo , Male , Nitriles , Triazines , Tuberculosis, Spinal/epidemiology , Tuberculosis, Spinal/microbiology , Tuberculosis, Spinal/pathology , United States/epidemiology
10.
Spine (Phila Pa 1976) ; 45(3): 163-169, 2020 Feb 01.
Article in English | MEDLINE | ID: mdl-31513101

ABSTRACT

STUDY DESIGN: A cross-sectional observational study. OBJECTIVE: This study aims to determine the diagnostic accuracy, sensitivity, and specificity of the Xpert MTB/RIF assay (Mycobacterium Tuberculosis/Rifampicin resistance) for the detection of spinal Tuberculosis (TB) and rifampicin (RIF) resistance. SUMMARY OF BACKGROUND DATA: The Spinal TB is often a paucibacillary extra pulmonary tuberculosis which gives a major challenge in early diagnosis and initializing the correct anti-tubercular treatment (ATT). Due to its rapidity and sensitivity, the dependence and reliability on the Xpert MTB/RIF assay has increased in the last few years. The studies describing accuracy of the Xpert MTB/RIF assay in spinal TB are scanty. METHODS: This institutional review board-approved study included 360 diagnosed spinal TB patients. To determine the accuracy of the Xpert MTB/RIF assay, it was compared with other diagnostic tests like histopathology, acid fast bacilli (AFB) smear, culture, and drug sensitivity testing (DST). RESULTS: The Xpert MTB/RIF assay showed 86.3% sensitivity and 85.3% specificity when compared with culture for the diagnosis of Spinal TB and showed 75.86% sensitivity, 96.12% specificity for RIF resistance when compared to DST. Four cases were false positive and 11 cases were false negative for RIF resistance on the Xpert MTB/RIF assay. CONCLUSION: The Xpert MTB/RIF assay is an efficient technique for the rapid diagnosis of spinal TB; however, a clinician should not solely rely on it for starting ATT. As there are false results also with this test which should be read cautiously and be well correlated with culture and DST pattern to guide the start of sensitive drug regimen only. The purpose is to prevent exposure of the second line drugs to false cases found on the Xpert MTB/RIF assay and avoid emergence of new acquired drug resistance. LEVEL OF EVIDENCE: 4.


Subject(s)
Antibiotics, Antitubercular/pharmacology , Molecular Typing , Rifampin/pharmacology , Tuberculosis, Multidrug-Resistant , Tuberculosis, Spinal , Cross-Sectional Studies , Humans , Molecular Typing/methods , Molecular Typing/standards , Reproducibility of Results , Sensitivity and Specificity , Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis, Multidrug-Resistant/microbiology , Tuberculosis, Spinal/diagnosis , Tuberculosis, Spinal/microbiology
11.
Z Gastroenterol ; 57(12): 1487-1492, 2019 Dec.
Article in German | MEDLINE | ID: mdl-31826280

ABSTRACT

Increasing numbers of active tuberculosis in Germany were recorded in the last years. Thus, also extrapulmonary manifestations of tuberculosis gain clinical significance as differential diagnoses, especially when a metastatic tumor disease is suspected. We report the case of a 77-year-old male patient who presented with unilateral leg pain and B symptoms. Further investigations revealed an osteolytic mass in the sacrum as well as CT-morphological findings consistent with metastatic gastric cancer. However, transgastric biopsies showed necrotising granuloma with giant cells leading to molecular and cultural detection of Mycobacterium tuberculosis instead of suspected neoplastic tissue. A nine-month treatment regimen for suspected disseminated tuberculosis with bone involvement was initiated according to national guidelines. Clinical and radiological follow up examinations after treatment completion showed complete remission.


Subject(s)
Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Miliary/diagnosis , Tuberculosis, Osteoarticular/diagnosis , Tuberculosis, Spinal/diagnosis , Aged , Antitubercular Agents/therapeutic use , Biopsy , Diagnosis, Differential , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Germany , Humans , Male , Stomach Neoplasms/pathology , Tomography, X-Ray Computed , Treatment Outcome , Tuberculosis, Miliary/drug therapy , Tuberculosis, Miliary/microbiology , Tuberculosis, Osteoarticular/drug therapy , Tuberculosis, Osteoarticular/microbiology , Tuberculosis, Spinal/drug therapy , Tuberculosis, Spinal/microbiology
14.
BMJ Case Rep ; 12(11)2019 Nov 24.
Article in English | MEDLINE | ID: mdl-31767612

ABSTRACT

We report a case of infectious spondylitis in a 52-year-old woman who presented with progressive difficulty in walking. The patient had a 2-month long history of neurological symptoms, which progressed rapidly to paraplegia, following her admission. Imaging studies demonstrated the presence of vertebral lesions as well as additional tissue with inflammatory elements in the spinal canal, which caused a mass effect. In combination with the presence of increased cells and protein in the cerebrospinal fluid (CSF), the differential was steered towards causes of infectious spondylitis, primarily tuberculosis. However, brucellosis was also considered, as it is endemic in our area. Prompt surgical decompression produced biopsy samples, which confirmed the presence of granulomatous inflammation. The patient was started on an empiric regimen covering both for tuberculosis and brucellosis, and gradually regained full mobility in her lower limbs. The differential of infectious spondylitis is discussed, with an emphasis on the differentiation between tuberculosis and brucellosis.


Subject(s)
Brucellosis/diagnosis , Granuloma/diagnosis , Spondylitis/diagnosis , Tuberculosis, Spinal/diagnosis , Brucellosis/microbiology , Diagnosis, Differential , Female , Granuloma/microbiology , Granuloma/physiopathology , Humans , Middle Aged , Mobility Limitation , Spondylitis/microbiology , Spondylitis/physiopathology , Tuberculosis, Spinal/microbiology
15.
PLoS One ; 14(10): e0223391, 2019.
Article in English | MEDLINE | ID: mdl-31581274

ABSTRACT

BACKGROUND: Linezolid has shown strong antimicrobial activity against multidrug-resistant (MDR)/rifampin-resistant strains of Mycobacterium tuberculosis. Linezolid achieves clinical efficacy mainly through area under the concentration time curve/minimum inhibitory concentration ratio in the infected lesion site. Previous studies mainly focused on the relationship between linezolid concentrations in the blood and infected bone tissue when the blood drug concentration reached the peak 2 h after administration. However, we do not know whether linezolid can maintain the same bone/plasma ratio in infected bone tissue when the blood concentration reaches the trough level. Therefore, this study aimed to evaluate the penetrability of linezolid into bone tissue 24 h after administration in patients with MDR spinal tuberculosis (TB). METHODS: Nine MDR spinal TB patients, who received a treatment regimen including linezolid and underwent surgery, were enrolled prospectively from April 2017 to March 2019. Blood and diseased bone tissue specimens were collected simultaneously during operations 24 h after taking 600 mg of linezolid orally. Linezolid concentrations in plasma and diseased bone tissue specimens were determined by high-performance liquid chromatography-tandem mass spectrometry. RESULTS: Following a 600 mg oral administration of linezolid 24 h before surgery, median concentrations of linezolid in plasma and diseased bone tissue for the 9 patients were 1.98 mg/L (range 0.30-3.44 mg/L) and 0.60 mg/L (range 0.18-2.13 mg/L), respectively, at resection time. The median diseased bone/plasma linezolid concentration ratio was 0.48 (range 0.30-0.67). Pearson's correlation analysis showed that linezolid concentrations in the plasma were positively related to those in diseased bone tissue (r = 0.949, p < 0.001). CONCLUSIONS: After 24 h of medication, linezolid still had good penetrability into diseased bone tissue in patients with MDR spinal TB.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Bone and Bones/drug effects , Linezolid/pharmacokinetics , Adult , Aged , Anti-Bacterial Agents/administration & dosage , Chromatography, High Pressure Liquid , Drug Monitoring , Female , Humans , Linezolid/administration & dosage , Male , Middle Aged , Permeability , Tandem Mass Spectrometry , Time Factors , Tissue Distribution , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/microbiology , Tuberculosis, Spinal/drug therapy , Tuberculosis, Spinal/microbiology
16.
Medicine (Baltimore) ; 98(23): e15941, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31169716

ABSTRACT

Increasing number of studies have shown growing incidence of lumbosacral tuberculosis and its complications. However, the treatment options for this disorder are still limited.To evaluate the long-term therapeutic effect and prognosis of minimally invasive puncture catheter drainage and Isoniazid local chemotherapy for the treatment of lumbosacral tuberculosis without neural symptoms under the guidance of computed tomography (CT).A total of 45 patients with asymptomatic lumbosacral tuberculosis were treated by minimally invasive catheter drainage under CT guidance. Forty-two cases had been followed up, which included 22 women and 20 men with an average age of 36.45 years old. Isoniazid was injected locally and antituberculotic drugs were administered for postoperative treatment. Oswestry Disability Index (ODI), visual analogue scale (VAS) evaluation and Cobb angle were recorded before and after operation.Forty-two patients had been followed up and the follow-up term was from 1.2 to 8.5 years (average 60 months). All patients were healed without recurrent cases. The ODI were improved from 14.86 ±â€Š2.02 before operation to 1.48 ±â€Š1.55 after operation. The post-operative (4.19 ±â€Š1.17) VAS score was improved compared to the pre-operative VAS score (0.55 ±â€Š0.55). The post-operative Cobb angle (6.19°â€Š±â€Š3.85°) was also improved relatively to the preoperative Cobb angle (5.90°â€Š±â€Š3.71°).Minimally invasive puncture catheter drainage combined with Isoniazid local chemotherapy is an effective method for lumbosacral tuberculosis without neural symptom. Meanwhile, it can be applied for the treatment of spinal tuberculosis before open surgery.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Catheterization/methods , Drainage/methods , Lumbosacral Region/microbiology , Tuberculosis, Spinal/therapy , Adult , Drainage/instrumentation , Female , Humans , Lumbar Vertebrae , Lumbosacral Region/surgery , Male , Middle Aged , Treatment Outcome , Tuberculosis, Spinal/microbiology
17.
Tuberculosis (Edinb) ; 116: 35-36, 2019 05.
Article in English | MEDLINE | ID: mdl-31153516

ABSTRACT

The authors present a case of a probable Pott disease from central/southern Mexico, dated 300 BC to 500 AD. This case highlights the importance of iconotopsy/iconodiagnosis for a better description of the natural history of diseases, especially as a complement to morphological analyses of human remains (paleopathology) and laboratory exams (DNA or immunology testing).


Subject(s)
Paleopathology , Posture , Sculpture/history , Tuberculosis, Spinal/history , History, Ancient , Humans , Mexico , Tuberculosis, Spinal/diagnosis , Tuberculosis, Spinal/microbiology , Tuberculosis, Spinal/physiopathology
18.
Eur Rev Med Pharmacol Sci ; 23(2 Suppl): 201-209, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30977887

ABSTRACT

The term spondylodiscitis describes the infection of both the intervertebral disc space and the adjacent vertebrae. Pyogenic Vertebral Osteomyelitis (PVO) is more common in older patients (mean age 59-69 years) with a male preponderance (52-69%). Recent studies reported an alarming increase of incidence over the last 20 years, due to the increase of diagnostic sensibility, the increase of the average lifetime and to the consequent association of chronic disabling pathologies, of immunosuppression, of surgical or invasive procedure. Improvements in radiological diagnosis, surgical techniques, and management of antimicrobial therapy have greatly improved PVO clinical outcome, but morbidity remains significant mostly because of the delay of diagnosis. The non-specific features of this infection can lead to underestimate the patient conditions, ending to a significant delay in diagnosis, reported from 30 to 90 days, and consequently to severe impairments, such as spine deformity and permanent neurological deficit. The duration of medical treatment is not yet established, and further randomized trials are needed to define it.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Tuberculosis, Spinal/drug therapy , Administration, Oral , Anti-Bacterial Agents/administration & dosage , Humans , Injections, Intravenous , Tuberculosis, Spinal/diagnostic imaging , Tuberculosis, Spinal/microbiology
19.
J Orthop Surg Res ; 14(1): 24, 2019 Jan 22.
Article in English | MEDLINE | ID: mdl-30670055

ABSTRACT

BACKGROUND: There was a controversy about surgery approach of thoracic and lumbar tuberculosis (TB) treatment. The aim of this study was to compare the microbiology outcomes of the drainage liquid and the clinical outcomes of a posterior and anterior approach in the treatment of thoracic and lumbar TB. MATERIALS AND METHODS: A total of 105 patients were enrolled in this prospective study from February 2011 to September 2015. Patients were divided into two groups: group A (51 patients, posterior approach surgery) and group B (54 patients, anterior approach surgery). Intraoperative TB samples were sent for Mycobacterium tuberculosis culture (MTBC). Drainage fluid was postoperatively collected for polymerase chain reaction (PCR), acid-fast strains (AFS), MTBC, and DNA molecular detection (DNAMD) analyses. Compare the drainage liquid positive rate of the two groups and estimate relationship between the positive results of drainage fluid and the lesion region. In addition, the clinical outcomes including the bony fusion, relapse rate, complications, and neurological status were collected. RESULTS: There was no significant difference in the positive rate of AFS, PCR, DNAMD, MTBC, or any positive rate (APR) of drainage liquid between the two groups (P > 0.05). In both groups, the MTBC-positive rate of postoperative drainage fluid was significantly lower than that of the intraoperative sample (P < 0.01). There was no significant relationship between APR and the lesion region (P > 0.05). All the patients had at least 2 years of follow-up, with an average of 34.4 ± 15.8 months. There were four patients in group A and two patients in group B who had recurrent spine TB, and the rest of the patients had fusion in the surgical area. There was no significant difference in the incidence of TB recurrence or other complications between the two groups (P > 0.05). All the patients with neurological dysfunction had improved after surgery. CONCLUSION: Compared with anterior approach surgery, posterior approach surgery had equal effectiveness of debridement. The two kinds of surgery can effectively clear the lesions surrounding the spine and heal thoracic and lumbar TB.


Subject(s)
Debridement/methods , Lumbar Vertebrae/diagnostic imaging , Thoracic Vertebrae/diagnostic imaging , Tuberculosis, Spinal/diagnostic imaging , Adult , Drainage/methods , Female , Humans , Lumbar Vertebrae/microbiology , Lumbar Vertebrae/surgery , Male , Middle Aged , Postoperative Care/methods , Prospective Studies , Spinal Fusion/methods , Surgical Wound/diagnostic imaging , Surgical Wound/microbiology , Thoracic Vertebrae/microbiology , Thoracic Vertebrae/surgery , Treatment Outcome , Tuberculosis, Spinal/microbiology , Tuberculosis, Spinal/surgery , Young Adult
20.
Adv Exp Med Biol ; 1214: 23-30, 2019.
Article in English | MEDLINE | ID: mdl-29846908

ABSTRACT

During a routine abattoir inspection of pig carcasses and control activities of hunted wildlife in 2013, 118 large white pigs Sus scrofa domesticus, 474 Nebrodi black pigs and 135 wild boars Sus scrofa scrofa were submitted to anatomopathological examination to evaluate the presence of tuberculosis-like lesions. Localized and generalized granulomatous lesions were detected with a prevalence of about 25% in large white pigs, 13% in Nebrodi black pigs and 8.15% in wild boars. Localized lesions involved mainly the submandibular lymph nodes, but when the disease was spread throughout the body, the inner organs and, also, in some cases, udders and/or bones were injured. The highest prevalence of generalized lesions (15/30) was observed in large white pigs, the only ones in which tuberculous granuloma affected also the spine. The bovine tuberculous spondylitis cases observed showed some similarities with Pott disease in humans regarding aspect and localization of lesions and age of the affected animals.Tissue samples of the positive animals were collected and submitted to bacteriological analysis, and the bone samples were also subjected to histological and immunohistochemistry analysis. M. bovis was isolated in all the analysed samples, and the granuloma encapsulation was found often incomplete indicating that the disease was in an active phase. The presence of lesions associated to tuberculous spondylitis in pigs suggests the possibility to use this animal species as model for the study of Pott disease in humans.


Subject(s)
Disease Models, Animal , Mycobacterium bovis , Tuberculosis, Spinal , Animals , Animals, Wild , Humans , Mycobacterium bovis/physiology , Sus scrofa , Swine , Swine Diseases/microbiology , Swine Diseases/pathology , Tuberculosis, Spinal/microbiology , Tuberculosis, Spinal/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...